Outcomes for the Absorb Everolimus-Eluting Stent Are Acceptable at 1 to 2 Years, With Caveats
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Only registered members have full access to PracticeUpdate content.